NEW YORK (GenomeWeb News) – Response Genetics has entered into an agreement to sell $4 million of common stock through a private placement, the Los Angeles-based molecular diagnostics firm said this week.

Response Genetics said that it had inked an agreement with certain funds managed by Lansdowne Partners to acquire 3,057,907 shares of newly issued common stock for $1.30 per share.

The firm did not provide details regarding the use of the proceeds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.